National Research Council, Institute of Clinical Physiology, Italy
8
4
5
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Non-invasive Tests for Non-alcoholic Steato-hepatitis
Role: collaborator
Health Effects of CArdiac FluoRoscopy and MOderN RadIotherapy in PediatriCs - Radiotherapy
Role: collaborator
2-Brain Regulation to Achieve Improved Neuroprotection During Early Development
Role: collaborator
Global Research Initiative for Patients Screening on MASH
Role: collaborator
Severe/Uncontrolled Asthma From General Population to Clinical Setting: Update and Follow-up of the RItA Registry
Role: collaborator
Mastiha Treatment for Obese With NAFLD Diagnosis
Role: collaborator
Italian Web-based Cross-sectional Survey on COVID-19
Role: collaborator
Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging
Role: collaborator
All 8 trials loaded